Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven A Narod

Showing results (361-370 of 544) with videos related to

Pageof 55
Sort By:
Hereditary Cancer in Clinical Practice|January 1, 2020
Serum selenium level and cancer risk: a nested case-control studySteven A Narod, Tomasz Huzarski, Anna Jakubowska, et al.
The Lancet. Oncology|May 12, 2015
Clinical outcomes in women with breast cancer and a PALB2 mutation: a prospective cohort analysisCezary Cybulski, Wojciech Kluźniak, Tomasz Huzarski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2004
Estrogen receptor status in BRCA1- and BRCA2-related breast cancer: the influence of age, grade, and histological typeWilliam D Foulkes, Kelly Metcalfe, Ping Sun, et al.
Journal of the National Cancer Institute|November 25, 2010
Family history of cancer and cancer risks in women with BRCA1 or BRCA2 mutationsKelly Metcalfe, Jan Lubinski, Henry T Lynch, et al.
Journal of Cancer|October 31, 2015
Identification and Validation of a Five MicroRNA Signature Predictive of Prostate Cancer Recurrence and Metastasis: A Cohort StudyRobert K Nam, Yutaka Amemiya, Tania Benatar, et al.
Cancer Causes & Control : CCC|August 30, 2003
Reproductive factors and ovarian cancer risk in Jewish BRCA1 and BRCA2 mutation carriers (United States)Francesmary Modugno, Roxana Moslehi, Roberta B Ness, et al.
Breast Cancer Research and Treatment|August 2, 2014
Mammography screening and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a prospective studyVasily Giannakeas, Jan Lubinski, Jacek Gronwald, et al.
International Journal of Cancer|July 27, 2019
Blood arsenic levels and the risk of familial breast cancer in PolandWojciech Marciniak, Róża Derkacz, Magdalena Muszyńska, et al.
The Journal of Urology|June 19, 2012
Population based study of long-term rates of surgery for urinary incontinence after radical prostatectomy for prostate cancerRobert K Nam, Sender Herschorn, D Andrew Loblaw, et al.
British Journal of Cancer|May 19, 2021
PALB2 mutations and prostate cancer risk and survivalDominika Wokołorczyk, Wojciech Kluźniak, Klaudia Stempa, et al.
Pageof 55

Showing results (361-370 of 544) with videos related to

Sort By:
Pageof 55
Hereditary Cancer in Clinical Practice|January 1, 2020
Serum selenium level and cancer risk: a nested case-control studySteven A Narod, Tomasz Huzarski, Anna Jakubowska, et al.
The Lancet. Oncology|May 12, 2015
Clinical outcomes in women with breast cancer and a PALB2 mutation: a prospective cohort analysisCezary Cybulski, Wojciech Kluźniak, Tomasz Huzarski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2004
Estrogen receptor status in BRCA1- and BRCA2-related breast cancer: the influence of age, grade, and histological typeWilliam D Foulkes, Kelly Metcalfe, Ping Sun, et al.
Journal of the National Cancer Institute|November 25, 2010
Family history of cancer and cancer risks in women with BRCA1 or BRCA2 mutationsKelly Metcalfe, Jan Lubinski, Henry T Lynch, et al.
Journal of Cancer|October 31, 2015
Identification and Validation of a Five MicroRNA Signature Predictive of Prostate Cancer Recurrence and Metastasis: A Cohort StudyRobert K Nam, Yutaka Amemiya, Tania Benatar, et al.
Cancer Causes & Control : CCC|August 30, 2003
Reproductive factors and ovarian cancer risk in Jewish BRCA1 and BRCA2 mutation carriers (United States)Francesmary Modugno, Roxana Moslehi, Roberta B Ness, et al.
Breast Cancer Research and Treatment|August 2, 2014
Mammography screening and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a prospective studyVasily Giannakeas, Jan Lubinski, Jacek Gronwald, et al.
International Journal of Cancer|July 27, 2019
Blood arsenic levels and the risk of familial breast cancer in PolandWojciech Marciniak, Róża Derkacz, Magdalena Muszyńska, et al.
The Journal of Urology|June 19, 2012
Population based study of long-term rates of surgery for urinary incontinence after radical prostatectomy for prostate cancerRobert K Nam, Sender Herschorn, D Andrew Loblaw, et al.
British Journal of Cancer|May 19, 2021
PALB2 mutations and prostate cancer risk and survivalDominika Wokołorczyk, Wojciech Kluźniak, Klaudia Stempa, et al.
Pageof 55